MiR-1291 replacement therapy (Mirna Therapeutics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMiR-1291 replacement therapy (Mirna Therapeutics)

Drug Alias NamemicroRNA-1291microRNA-1291 replacement therapy (Pancreatic cancer)

ClassificationBiologics

Mechanisms of ActionUpdating

TargetsNot applicable

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Clinical)

Highest Status in ChinaN/A

Originator CompaniesSynlogic Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSynlogic Inc

Active IndicationsN/A

Inactive IndicationsPancreatic Neoplasms

ATC CodeN/A